A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.
Advertisement
NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.
A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.
